LY-293284 is a research chemical developed by the pharmaceutical company Eli Lilly and used for scientific studies. It acts as a potent and selective 5-HT1A receptor full agonist. It was derived through structural simplification of the ergoline based psychedelic LSD,[1] but is far more selective for 5-HT1A with over 1000× selectivity over other serotonin receptor subtypes and other targets.[2] It has anxiogenic effects in animal studies.[3]
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C19H26N2O |
Molar mass | 298.430 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |